UK Drug Pricing Scheme Talks Collapse: Industry Braces For Another Year Of High Rebates

The UK government and the pharma industry were unable to reach an agreement on changes to the country's voluntary pricing scheme (Shutterstock)

More from Government Payers

More from United Kingdom